In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...
A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a<a class="excerpt-read-more" href=" More ...
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received a pig kidney transplant.
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results